Accounts Submission

LASCAUX PHARMACEUTICALS LIMITED - Company Information

Company Accounts and Tax Online 03230603 Board of Directors 1.10.16 30.9.17 30.9.17 No description of principal activity false iso4217:GBP xbrli:pure 03230603 2015-10-01 2016-09-30 03230603 2017-09-30 03230603 2016-10-01 2017-09-30 03230603 2016-09-30 03230603 countries:EnglandWales 2016-10-01 2017-09-30 03230603 curr:PoundSterling 2016-10-01 2017-09-30 03230603 uk-bus:PrivateLimitedCompanyLtd 2016-10-01 2017-09-30 03230603 uk-bus:Micro-entities 2016-10-01 2017-09-30 03230603 uk-bus:AuditExempt-NoAccountantsReport 2016-10-01 2017-09-30 03230603 uk-bus:FullAccounts 2016-10-01 2017-09-30 03230603 uk-bus:RegisteredOffice 2016-10-01 2017-09-30 03230603 uk-bus:Director1 2016-10-01 2017-09-30 03230603 uk-bus:Director1 2016-10-01 03230603 uk-bus:Director1 2017-09-30 03230603 core:AfterOneYear 2017-09-30 03230603 core:AfterOneYear 2016-09-30 03230603 core:WithinOneYear 2017-09-30 03230603 core:WithinOneYear 2016-09-30 03230603 core:WithinOneYear 2016-10-01 2017-09-30 03230603 core:AfterOneYear 2017-09-30 03230603 core:AfterOneYear 2016-09-30 03230603 core:AfterOneYear 2016-10-01 2017-09-30 03230603 core:ShareCapital 2017-09-30 03230603 core:ShareCapital 2016-09-30 03230603 core:RevaluationReserve 2017-09-30 03230603 core:RevaluationReserve 2016-09-30 03230603 core:RetainedEarningsAccumulatedLosses 2017-09-30 03230603 core:RetainedEarningsAccumulatedLosses 2016-09-30 03230603 1 2016-10-01 2017-09-30

Company Registration Number:
03230603 (England and Wales)

Unaudited micro entity accounts for the year ended 30 September 2017

Period of accounts

Start date: 01 October 2016

End date: 30 September 2017

Contents of the Financial Statements

for the Period Ended 30 September 2017


Company Information - 3
Balance sheet - 4

Balance sheet

As at 30 September 2017

	2017 £	2016 £
Current assets:	3,782	43,115
Creditors: amounts falling due within one year:		( 1,997 )
Net current assets (liabilities):	3,782	41,118
Total assets less current liabilities:	3,782	41,118
Creditors: amounts falling due after more than one year:	( 17,126 )	( 60,811 )
Total net assets (liabilities):	( 13,344 )	( 19,693 )
Capital and reserves:	( 13,344 )	( 19,693 )

Balance sheet continued

For the year ending 30 September 2017 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions of the small companies regime applicable to micro-entities.

This report was approved by the board of directors on 29 June 2018
And Signed On Behalf Of The Board By:

Name: Prof Thomas Rademacher
Status: Director

The notes form part of these financial statements



Registered office:		2a Dunmore Court Lascaux Pharma 2a Dunmore Court, Wootton Road Abingdon Oxon OX13 6BH


Company Registration Number:		03230603 (England and Wales)

Accounts Submission